FDA Adverse Event Injury Summary report: N

MRGFUS EXABLATE

MDR report key: 2147572 · Received May 22, 2011

Report

Report Number
9615058-2011-00001
Event Type
Injury
Date Received
May 22, 2011
Date of Event
May 14, 2011
Report Date
May 22, 2011
Manufacturer
INSIGHTEC LTD.
Product Code
NRZ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE HAS BEEN DIAGNOSED TO WORK ACCORDING TO IT'S SPECIFICATIONS. REASON OF ADVERSE EVENT IS USER ERROR. TREATING PHYSICIAN FAILED TO NOTICE ORGANS MOVEMENT. INSIGHTEC TRAINING MATERIAL ALREADY EXPLAINS AND ADDRESS SUCH SITUATIONS THUS WE DID NOT FIND ANY ROOM FOR IMPROVEMENT OF PROCEDURE. SITE WAS RE TRAINED FOLLOWING THIS EVENT. PLEASE SEE FULL ANALYSIS REPORT ATTACHED.

Description of Event or Problem · 1

THE PT: A (B)(6) YRS OLD, FEMALE, PRESENTING WITH FIBROID ATTRIBUTABLE MENORRHAGIA AND ABDOMINAL PAIN DURING THE LAST YEAR. MRI REVEALED AN INTRAMURAL POSTERIOR FIBROID, VOLUME OF APPROX 50CC (41MM X 41MM X 53MM); HYPO-INTENSE ON T2W IMAGING. TREATMENT WAS PLANNED FOR A SINGLE SESSION, BUT AT THE END OF THE FIRST SESSION THE TREATING PHYSICIANS FOUND OUT THAT A SIGNIFICANT PORTION OF THE FIBROID REMAINED PERFUSED AND DECIDED COMPLETE THE TREATMENT IN A SECOND SESSION ON THE FOLLOWING DAY (SINCE THE PT LIVES FAR FROM THE HOSP). TREATMENT SESSIONS TOOK PLACE ON (B)(6), 2011 AND (B)(6), 2011. BOTH TREATMENT SESSIONS WERE DESCRIBED AS UNEVENTFUL. THE PT WAS PLANNED TO STAY AT THE HOSP OVERNIGHT (WHICH IS STANDARD OF CARE IN (B)(6)). SHE WAS EXPECTED TO BE DISCHARGED ON (B)(6). HOWEVER, DUE TO COMPLAINTS ABOUT SPASTIC ABDOMINAL PAIN, THE PT REMAINED ANOTHER NIGHT FOR OBSERVATION IN THE HOSP. IN THE MORNING OF (B)(6), THE PT STILL COMPLAINED ABOUT ABDOMINAL PAIN AND HER MEASURED PULSE WAS APPROX 105 BPM, AND CT REVEALED AIR IN THE ABDOMINAL CAVITY SUGGESTING BOWEL PERFORATION. THE PT UNDERWENT EMERGENCY LAPAROTOMY WHERE A TERM...

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MRGFUS EXABLATE FOCUSED ULTRASOUND NRZ INSIGHTEC LTD. 2100

Patients

Seq Age Sex Outcome Treatment
1 40 YR Hospitalization| R